News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Servier on Trial Over Diabetes-Diet Pill
May 14, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(Reuters) - French drugmaker Servier and its founder went on trial on Monday accused of misleading patients and authorities about a diabetes drug often prescribed for weight loss that officials blame for at least 500 deaths.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
MORE ON THIS TOPIC
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
February 6, 2026
·
1 min read
·
Tristan Manalac
Drug pricing
TrumpRx Website Set To Launch Thursday Evening After Delay
February 5, 2026
·
1 min read
·
Dan Samorodnitsky
Job Trends
3 Top Challenges Facing Regulatory Professionals Right Now
February 5, 2026
·
4 min read
·
Angela Gabriel
FDA
FDA’s Commissioner’s Priority Voucher Program ‘Shrouded in Secrecy,’ Democratic Rep Says
February 4, 2026
·
2 min read
·
Tristan Manalac